Lineage Cell Therapeutics, Inc. (DE:BT3)
XASE:BT3
Summary of all the Indicators
Overall Consensus
Strong Sell
3Bullish
4Neutral
15Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Lineage Cell Therapeutics, Inc.’s (BT3) Moving Averages Convergence Divergence (MACD) indicator is -0.05, suggesting Lineage Cell Therapeutics, Inc. is a Sell.
Lineage Cell Therapeutics, Inc.’s (BT3) 20-Day exponential moving average is 1.12, while Lineage Cell Therapeutics, Inc.’s (BT3) share price is €1.35, making it a Sell.
Lineage Cell Therapeutics, Inc.’s (BT3) 50-Day exponential moving average is 1.21, while Lineage Cell Therapeutics, Inc.’s (BT3) share price is €1.35, making it a Sell.
Lineage Therap (BT3) Pivot Points
Classic
1.11
1.11
1.11
1.11
1.11
1.11
1.11
Fibonacci
1.11
1.11
1.11
1.11
1.11
1.11
1.11
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Lineage Therap (BT3) Moving Averages
MA5
1.09Sell
1.08Sell
MA10
1.08Sell
1.09Sell
MA20
1.10Sell
1.12Sell
MA50
1.22Sell
1.21Sell
MA100
1.33Sell
1.27Sell
MA200
1.34Sell
1.22Sell
Lineage Cell Therapeutics, Inc.’s (BT3) 10-Day exponential moving average is 1.09, while Lineage Cell Therapeutics, Inc.’s (BT3) share price is €1.35, making it a Sell.
Lineage Cell Therapeutics, Inc.’s (BT3) 100-Day exponential moving average is 1.27, while Lineage Cell Therapeutics, Inc.’s (BT3) share price is €1.35, making it a Sell.
Lineage Cell Therapeutics, Inc.’s (BT3) stock price is €1.35 and Lineage Cell Therapeutics, Inc.’s (BT3) 50-day simple moving average is 1.22, creating a Sell signal.
Lineage Cell Therapeutics, Inc.’s (BT3) stock price is €1.35 and Lineage Cell Therapeutics, Inc.’s (BT3) 100-day simple moving average is 1.33, creating a Sell signal.
Lineage Cell Therapeutics, Inc.’s (BT3) stock price is €1.35 and Lineage Cell Therapeutics, Inc.’s (BT3) 200-day simple moving average is 1.34, creating a Sell signal.
Lineage Therap (BT3) Technical Indicators
RSI (14)
39.02
Neutral
STOCH (9,6)
66.67
Neutral
STOCHRSI (14)
74.76
Neutral
MACD (12,26)
-0.05
Sell
ADX (14)
14.01
Buy
Williams %R
-58.49
Buy
CCI (14)
-107.34
Buy
ATR (14)
0.03
-
Ultimate Oscillator
32.69
Neutral
ROC
-6.43
Sell
Lineage Cell Therapeutics, Inc.’s (BT3) Relative Strength Index (RSI) is 39.02, creating a Neutral signal.
Lineage Cell Therapeutics, Inc.’s (BT3) Trend Strength Indicator (ADX) is 14.01, creating a Buy signal.
Lineage Cell Therapeutics, Inc.’s (BT3) Commodity Channel Index (CCI) is -107.34, creating a Buy signal.
Lineage Cell Therapeutics, Inc.’s (BT3) Price Rate of Change (ROC) is -6.43, creating a Sell signal.
FAQ
Is BT3 a Buy, Hold, or Sell?
Based on BT3’s technical indicators, BT3 is a Strong Sell.
What is BT3’s RSI (14)?
BT3’s RSI (14) is 39.02, which suggests BT3 is a Neutral.
What is BT3’s MACD?
BT3’s MACD is -0.05, which suggests BT3 is a Sell.
What is BT3’s 5-day moving average?
BT3’s 5-day moving average is 1.09, which suggests BT3 is a Sell.
What is BT3’s 20-day moving average?
BT3 20-day moving average is 1.10, which suggests BT3 is a Sell.
What is BT3’s 50-day moving average?
BT3’s 50-day moving average is 1.22, which suggests BT3 is a Sell.
What is BT3’s 200-day moving average?
BT3’s 200-day moving average is 1.34, which suggests BT3 is a Sell.
What is BT3’s Williams % R (14)?
BT3’s Williams % R (14) is -58.49, which suggests BT3 is a Buy.
What is BT3’s CCI (14)?
BT3’s CCI (14) is -107.34, which suggests BT3 is a Buy.
What is the share price of Lineage Cell Therapeutics, Inc.?
Lineage Therap's share price is N/A€.